Literature DB >> 26413883

Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma--an analysis from the Austrian Myeloma Registry.

Wolfgang Willenbacher1,2, Ella Willenbacher1, Claudia Zelle-Rieser3, Rainer Biedermann4, Roman Weger2, Karin Jöhrer3, Andrea Brunner5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26413883     DOI： 10.3109/10428194.2015.1099646

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.

Authors:  Fabienne Lucas; Michael Pennell; Ying Huang; Don M Benson; Yvonne A Efebera; Maria Chaudhry; Tiffany Hughes; Jennifer A Woyach; John C Byrd; Suohui Zhang; Desiree Jones; Xiangnan Guan; Christin E Burd; Ashley E Rosko
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-21       Impact factor: 5.742

2.  A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.

Authors:  L E Franssen; M W H Roeven; W Hobo; R Doorn; R Oostvogels; J H F Falkenburg; N W van de Donk; M G D Kester; H Fredrix; K Westinga; I Slaper-Cortenbach; E Spierings; M J Kersten; H Dolstra; T Mutis; N Schaap; H M Lokhorst
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

3.  T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.

Authors:  Claudia Zelle-Rieser; Shanmugapriya Thangavadivel; Rainer Biedermann; Andrea Brunner; Patrizia Stoitzner; Ella Willenbacher; Richard Greil; Karin Jöhrer
Journal:  J Hematol Oncol       Date:  2016-11-03       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.